Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ASO Visual Abstract: High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival Following Resection of Extremity and Truncal Soft-Tissue Sarcoma.
Traweek RS, Lyu H, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. Traweek RS, et al. Among authors: nassif ef. Ann Surg Oncol. 2024 Jun;31(6):4150-4151. doi: 10.1245/s10434-024-15201-3. Ann Surg Oncol. 2024. PMID: 38546800 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36161369
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
Traweek RS, Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. Traweek RS, et al. Among authors: nassif ef. Ann Surg Oncol. 2024 Jun;31(6):4138-4147. doi: 10.1245/s10434-024-15074-6. Epub 2024 Feb 23. Ann Surg Oncol. 2024. PMID: 38396039
The immune landscape of undifferentiated pleomorphic sarcoma.
Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. Lazcano R, et al. Among authors: nassif ef. Front Oncol. 2022 Oct 12;12:1008484. doi: 10.3389/fonc.2022.1008484. eCollection 2022. Front Oncol. 2022. PMID: 36313661 Free PMC article.
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.
Traweek RS, Cope BM, Roland CL, Keung EZ, Nassif EF, Erstad DJ. Traweek RS, et al. Among authors: nassif ef. Front Oncol. 2022 Nov 10;12:1006959. doi: 10.3389/fonc.2022.1006959. eCollection 2022. Front Oncol. 2022. PMID: 36439412 Free PMC article. Review.
The Landscape of Immunotherapy for Retroperitoneal Sarcoma.
Gingrich AA, Nassif EF, Roland CL, Keung EZ. Gingrich AA, et al. Among authors: nassif ef. Curr Oncol. 2023 Feb 9;30(2):2144-2158. doi: 10.3390/curroncol30020165. Curr Oncol. 2023. PMID: 36826126 Free PMC article. Review.
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Nassif EF, et al. Int J Cancer. 2022 Jun 15;150(12):2012-2024. doi: 10.1002/ijc.33956. Epub 2022 Feb 18. Int J Cancer. 2022. PMID: 35128664 Free article.
23 results